In addition, no studies have specifically evaluated the role of ALDH1A1 in predicting prognosis of triple-negative breast cancer (TNBC: estrogen receptor negative (ER-), progesterone receptor negative (PR-), human epidermal growth factor receptor 2 negative (HER2-)). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.